Clinical trial
Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral…
NCT00322621 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00322621 |
|---|---|
| Title | Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) |
| Official title | Maintenance of Effect of Duloxetine 60 mg Once Daily in Patients With Diabetic Peripheral Neuropathic Pain |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetic Neuropathies |
| Intervention type | Drug |
| Interventions | Duloxetine |
| Enrollment | 216 |
| Start date | Apr 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | May 8, 2006 |
| Last update posted | Feb 7, 2011 |
| Countries | Brazil, France, Germany, Italy |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: